19-year-old Neil Fachon had just begun a clinical trial at The Burzynski Clinic to treat his DIPG, a rare form of cancer that Neil developed within 15 months of accepting HPV and meningitis vaccines.

Then the FDA demanded the trial stop.

According to Neil’s father Dean, the FDA claimed that the drug to be trialed — a substance called antineoplaston that Dr. Burzynski has been manufacturing since he developed it in the 70s (yes, the 70s!) — would have to be manufactured in an entirely different and much more expensive way before any trial could take place.

Neil Fachon never got to participate in the clinical trial he signed up for, and he has since passed away.

The Fachon’s book: https://dipgbook.com/

Neil’s parents tell CHD’s Stephanie Locricchio the full story:

https://live.childrenshealthdefense.org/chd-tv/shows/good-morning-chd/what-is-dipg/?utm_source=sovren&utm_medium=social&utm_campaign=chdtvpromo&utm_id=20240828